Table 4
Comparison with overseas series
| SWSAHS 1993 & 1996 | Glasgow, 1991–220 | Scotland, 199516 | France, 1987–813 | |
|---|---|---|---|---|
| NPD=no pathological diagnosis; NSCLC=non-small cell lung cancer; NR=not recorded. | ||||
| n | 527 | 262 | 3855 | 615 |
| M:F (%) | 70:30 | 66:34 | 61:39 | 90:10 |
| Median age (years) | 68 | NR | 70 | NR |
| >75 years | 21% | 12% | NR | 21% |
| Pathology | All lung cancer | All lung cancer | All lung cancer | NSCLC |
| NPD | 9% | 21% | 26% | NR |
| No treatment overall | 28% | 38% | 43% | NR |
| No treatment in NSCLC | 25% | NR | NR | 18% |
| Median survival (months) | 6.7 | NR | 3.6 | NR |
| 3 year survival | 11% | 9% | 7% | |
| 18 month survival in NSCLC | 22% | NR | NR | 30–35% |
